SavedAdd your journal

Journals / Journal of Clinical and Analytical Medicine / 2013 / Cilt: 4 - Sayı: 2

Hepatitit A seropozitifliği: Türkiye’de iki farklı hastanenin karşılaştırmalı sonuçları

Hepatitis A seropositivity: Comparative results of two hospitals in Turkey

Harun AGCA
Guliz TOKLU DOGAN
Pages
104–106
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Improvement of public and individual hygiene, education about hygiene, improvement of education and socioeconomic level of public and vaccination against HAV as recommended by the World Health Organisation may decrease the burden of HAV infection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Hepatitis A virus (HAV) is a ribonucleic acid (RNA) picornavirus transmitted by fecal-oral route.
📊
Key Findings & Data:HAV is usually silent or subclinic in children and on a worldwide scale only 5 % of infections are recognised clinically.
💡
Conclusion & Impact:Discussion: Improvement of public and individual hygiene, education about hygiene, improvement of education and socioeconomic level of public and vaccination against HAV as recommended by the World Health Organisation may decrease the burden of HAV infection.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Hepatitis A virus (HAV) is a ribonucleic acid (RNA) picornavirus transmitted by fecal-oral route. HAV is usually silent or subclinic in children and on a worldwide scale only 5 % of infections are recognised clinically. In this study we aimed to determine the seroprevalance of HAV seropositivity in two different hospitals in the Aegean region of Turkey. Material and Method: Serum samples, which were taken from patients to investigate hepatitis A antibodies administrated to Usak State Hospital and Tavsanli Doc. Dr. M. Kalemli State Hospital between January 2011 and December 2011 were investigated for hepatitis A seropositivity retrospectively. Age, sex, Anti HAV Ig G and Anti HAV Ig M were investigated. Results: 799 patients in Usak State Hospital and 461 patients in Tavsanli State hospital were investigated for Anti HAV Ig G and Anti HAV Ig M. 78 % were female, 22 % were male and mean age was 27,7 in Usak State Hospital. 54 % were female, 46 % were male, mean age was 38,0 in Tavsanli State Hospital. Anti-HAV Ig M positivity in Usak and Tavsanli State Hospital are 1,3 % and 0,6 % respectively. Anti- HAV Ig G positivity in Usak and Tavsanli State Hospital are 75,5 % and 80,4 % respectively. Discussion: Improvement of public and individual hygiene, education about hygiene, improvement of education and socioeconomic level of public and vaccination against HAV as recommended by the World Health Organisation may decrease the burden of HAV infection.

Özet

Amaç: Hepatit A virüsü, (HAV) ribonükleik asit (RNA) içeren picornavirüs olup fekal-oral yolla bulşmaktadır. HAV genellikle sessiz veya subklinik seyretmekte olup hastalığın sadece %5’i klinik olarak tanımlanabilmektedir. Bu çalışmada Türkiye’de Ege bölgesinde bulunan iki farklı hastenede HAV seropozitifliğinin belirlenmesi amaçlandı. Gereç ve Yöntem: Uşak Devlet Hastanesi ve Tavşanlı Devlet Hastanesi’ne başvuran ve Ocak 2011 ile Aralık 2011 döneminde serum alınarak hepatit A antikorları araştırılan hastalarda hepatitit A seropozitifliği retrospektif olarak irdelendi. Yaş, cinsiyet, Anti HAV Ig G and Anti HAV Ig M de araştırıldı. Bulgular: Uşak Devlet Hastanesinden 799, Tavsşanlı Devlet Hastanesi’nden 461 hasta Anti HAV Ig G ve Anti HAV Ig M seropozitifliği açısından incelendi. Uşak Devlet Hastanesi’nde hastaların % 78’i kadın, % 22’si erkek, yaş ortalaması 27,7 idi. Tavşanlı Devlet Hastanesi’nde hastaların % 54’ü kadın, % 46’sı erkek ve yaş ortalaması 38 idi. Uşak ve Tavşanlı Devlet Hastanelerinde Anti-HAV Ig M pozitifliği sırasıyla % 1,3 ve % 0,6 olarak bulundu. Anti-HAV Ig G pozitifliği ise Uşak ve Tavşanlı’da sırasıyla % 75,5 ve % 80,4 olarak bulundu. Sonuç: Toplum ve bireylerin hijyen düzeyinin geliştirilmesi, hijyen konusunda eğitim verilmesi, eğitim ve sosyoekeonomik seviyenin geliştirilmesi, Dünya Sağlık Örgütü önerileri doğrultusunda hepatit A aşısının uygulanması hepatit A enfeksiyonu sıklığının azalmasına yol açabilecektir.

🔖

Cite This Article

AGCA, H., DOGAN, G. T. (2022). Hepatitit A seropozitifliği: Türkiye’de iki farklı hastanenin karşılaştırmalı sonuçları. Journal of Clinical and Analytical Medicine, Cilt: 4 - Sayı: 2, 104–106. https://ajindex.com/articles/561584

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Forbes A, Williams R. Increasing age- an important prognostic factor in hepaptitis A virus infection. J R Coll Physician London 1988;22:237-9
  2. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med 1985;313:1059-67
  3. US Centers for Disease Control and Prevention. Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis- United States, 2002-2004. MMWR Morb Mortal Wkly Rep 2005;54:453-6
  4. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992;10(Suppl 1):S15-7
  5. Forbes A, Williams R. Changing epidemiology and clinical aspects of hepatitis A. Br Med Bull1990;46:303-18
  6. Szmuness DJL, Purcell RH, Stevens CE, Wong DC, Ikram H et al. The prevalance of antibody to hepatitis antigen in various parts of the world: a pilot study. Am J Epidemiol 1977;106:392-8
  7. Lee CH, Ang LW, Chiew PKT, James L, Goh KT. Changing epidemiologic patterns of hepatitis A infection in Singapore. Ann Acad Med Singapore 2011;40:439-47
  8. Kurugol Z, Koturoglu G, Aksit S, Ozacar T. Seroprevalance of hepatitis A infection in the Turkish Republic of Northern Cyprus. Turk J Med Sci 2009;39(1):109-13
  9. Kanra G, Tezcan S, Badur S. Turkish National Study Team. Hepatitis A seropre- valance in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002;44:204-10
  10. Akbulut A, Kilic SS, Felek S, Akbulut HH. The prevalance of hepatitis A in the Elazig region. Turk J Med Sci1996;26:375-8
  11. Colak D, Ogunc D, Gunseren F, Velipasaoglu S, Aktekin MR, Gultekin M. Sero- prevalance of hepatitis A and E viruses in pediatric age groups in Turkey. Acta Microbiol Immunol Hung 2002;49:93-7
  12. Sencan I, Sahin I, Kaya D, Oksuz S, Yildirim M. Assessment of HAV and HEV seroprevalance in children living in post-earthquake camps from Duzce, Turkey. Eur J Epidemiol 2004;19:461-5
  13. Okur M, Erbey F, Acar MN, Guven A, Kaya A. The seropositivity of hepatitis A in children between 0-18 years in the Van province and around. Duzce Medical Journal 2011;13(2):6-9
  14. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of hepatitis A in Korea: Changes over the past 30 years. J Korean Med Sci 2011;26:791-6
  15. Heng BH, Goh KT, Doraisingham S, Quek GH. Prevalance of hepatitis A virus infection among sewage workers in Singapore. Epidemiol Infect 1994;113:121-8
  16. Pham B, Duval B, De Serres G et al. Seroprevalance of